Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT01106794 : Molecular Analysis of Samples From Patients With Diffuse Intrinsic Pontine Glioma and Brainstem Glioma
Phase
AgesMin: N/A Max: 21 Years
Eligibility
Inclusion Criteria:

- Patients of any age with clinical and radiologic diagnosis of diffuse intrinsic
pontine glioma

- Patients with other high-grade gliomas originating in the brainstem

- Patients with focal gliomas (WHO grade I/II) of the brainstem

Exclusion Criteria:

- Patients with any type of infiltrative low grade (WHO grade I and II) or high grade
glioma (WHO grade III and IV) originating outside the brainstem

- Patients harboring primary brainstem tumors with other histologic diagnoses (e.g.,
PNET)
LinksPermanent Link to THIS page: http://virtualtrials.com/nct/display1trial.cfm?nct=NCT01106794      |      Link to official Clinicaltrials.gov listing
Locations
Washington, District of Columbia
Facility: Children's National Medical Center
Investigator: Javad Nazarian, PhD
Contact:
Email not avaialable




Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2018 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites